Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Centres of excellence verus community critical care.

Trust P.

Br J Gen Pract. 2004 May;54(502):397. No abstract available.

2.
3.

Audit.

Trust P.

Br J Gen Pract. 1997 Oct;47(423):661-2. No abstract available.

4.

Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.

Agabiti-Rosei E, Brown JJ, Brown WC, Fraser R, Trust PM, Lever AF, Morton JJ, Robertson JI.

Clin Endocrinol (Oxf). 1979 Mar;10(3):227-34.

PMID:
455738
5.

Tyramine and M.A.O. inhibitors in postural hypotension.

Trust PM.

Lancet. 1978 Feb 18;1(8060):386. No abstract available.

PMID:
75419
6.

Minoxidil for severe hypertension after failure of other hypotensive drugs.

Devine BL, Fife R, Trust PM.

Br Med J. 1977 Sep 10;2(6088):667-9.

7.

Renal hypertension: role for renin.

Brown JJ, Cuesta V, Davies DL, Lever AF, Morton JJ, Padfield PL, Robertson JI, Trust P.

Postgrad Med J. 1977;53 Suppl 3:31-4. No abstract available.

PMID:
928263
8.

Can angiotensin II cause renal hypertension when its plasma concentration is normal?

Brown JJ, Cuesta V, Davies DL, Lever AF, Morton JJ, Padfield PL, Robertson JI, Trust P, Bianchi G, Schalekamp MA.

Contrib Nephrol. 1977;8:57-60. No abstract available.

PMID:
891218
9.

Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.

Rosei EA, Fraser R, Morton JJ, Brown JJ, Lever AF, Robertson JI, Trust PM.

Am Heart J. 1977 Jan;93(1):124-5. No abstract available.

PMID:
12654
10.

Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.

Rosei EA, Trust PM, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI.

Clin Sci Mol Med Suppl. 1976 Dec;3:497s-499s.

PMID:
1071671
11.

The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.

Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.

Aust N Z J Med. 1976 Aug;6(3 Suppl):48-52.

PMID:
1071403
12.

Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.

Rosei EA, Brown JJ, Lever AF, Robertson AS, Robertson JI, Trust PM.

Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):809-15.

13.

Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.

Trust PM, Rosei EA, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI.

Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):799-803.

14.

Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.

Rosei EA, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JI, Trust PM.

Aust N Z J Med. 1976 Aug;6(3 Suppl):83-8.

PMID:
14627
15.

Mechanism of renal hypertension.

Brown JJ, Davies DL, Morton JJ, Robertson JI, Cuesta V, Lever AF, Padfield PL, Trust P.

Lancet. 1976 Jun 5;1(7971):1219-21.

PMID:
58263
16.

Letter: Emergency treatment of hypertensive crisis following clonidine withdrawal.

Brown JJ, Robertson AS, Rosei EA, Robertson JI, Lever AF, Trust PM.

Br Med J. 1976 May 29;1(6021):1341. No abstract available.

17.

Letter: Labetalol and clonidine in severe hypertension.

Rosel EA, Brown JJ, Trust PM, Lever AF, Robertson JI.

Lancet. 1976 Jan 10;1(7950):93. No abstract available.

PMID:
54616
18.

The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.

Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.

Prog Biochem Pharmacol. 1976;12:230-41.

PMID:
1019166
19.

Letter: Intravenous labetalol in severe hypertension.

Rosei EA, Trust PM, Brown JJ, Lever AF, Robertson JI.

Lancet. 1975 Nov 29;2(7944):1093-4. No abstract available.

PMID:
53581
20.

A case of hypopituitarism with diabetes insipidus and loss of thirst. Role of antidiuretic hormone and angiotensin II in the control of urine flow and osmolality.

Trust PM, Brown JJ, Chinn RH, Lever AF, Morton JJ, Padfield PL, Robertson JI, Ireland JT, Melville ID, Thomson WS.

J Clin Endocrinol Metab. 1975 Aug;41(2):346-53.

PMID:
1171897
21.

Glucose tolerance and insulin sensitivity in malnourished children.

Alleyne GA, Trust PM, Flores H, Robinson H.

Br J Nutr. 1972 May;27(3):585-92. No abstract available.

PMID:
5031184
22.

Further studies on carbohydrate metabolism in infantile malnutrition.

Alleyne GA, Flores H, Trust PM, Waterlow JC.

J Physiol. 1971 Mar;213(2):30P. No abstract available.

23.

Plasma renin concentration in the hypertensive diseases of pregnancy.

Brown JJ, Davies DL, Doak PB, Lever AF, Robertson JI, Trust P.

J Obstet Gynaecol Br Commonw. 1966 Jun;73(3):410-7. No abstract available.

PMID:
4957870
24.

Plasma-renin concentration in hypertensive disease of pregnancy.

Brown JJ, Davies DL, Doak PB, Lever AF, Robertson JI, Trust P.

Lancet. 1965 Dec 11;2(7424):1219. No abstract available.

PMID:
4158828

Supplemental Content

Support Center